Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 25, 2012 07:03 ET | Source: Genmab A/S

Nettoomsætning for Arzerra i andet kvartal 2012

Selskabsmeddelelse Den globale nettoomsætning for Arzerra i andet kvartal 2012 udgjorde GBP 14,9 mio. Genmab forventer en royaltybetaling på DKK 27 mio. København, Danmark, 25. juli 2012...
July 25, 2012 07:03 ET | Source: Genmab A/S

Arzerra Second Quarter 2012 Net Sales Figures

Company Announcement Arzerra worldwide net sales in Q2 2012 totaled GBP 14.9 million Genmab expects royalty payment of DKK 27 million Copenhagen, Denmark; July 25, 2012 – Genmab A/S...
July 12, 2012 15:09 ET | Source: Genmab A/S

Genmab indgår bredt samarbejde med Janssen Biotech, Inc. om DuoBody-platformen

Selskabsmeddelelse Genmab indgår DuoBody™ teknologisamarbejde Upfrontbetaling på USD 3,5 mio. til Genmab København, Danmark; 12. juli 2012 – Genmab A/S (OMX: GEN) har i dag meddelt, at...
July 12, 2012 15:09 ET | Source: Genmab A/S

Genmab Enters Broad Collaboration with Janssen Biotech, Inc. for DuoBody Platform

Company Announcement Genmab enters DuoBody™ technology collaboration $3.5 million upfront payment to Genmab Copenhagen, Denmark; July 12, 2012 – Genmab A/S (OMX: GEN) announced today it...
June 14, 2012 01:39 ET | Source: Genmab A/S

Tidspunktet for Genmabs daratumumab præsentation på EHA congress

Pressemeddelelse Mundtlig præsentation vil finde sted den 17. juni kl. 10.45-11.00 CEST i hovedauditoriet på EHA kongressen i Amsterdam Nye farmako-kinetiske (PK) data indgår i...
June 14, 2012 01:39 ET | Source: Genmab A/S

Timing of Genmab’s Daratumumab Presentations at EHA Congress

Media Release Oral presentation to take place June 17 10.45-11am CEST in the Main Auditorium at the EHA congress in Amsterdam New Pharmacokinetics (PK) data presented Three additional...
June 04, 2012 01:55 ET | Source: Genmab A/S

Genmab indgår DuoBody Teknologisamarbejde

Selskabsmeddelelse - Yderligere DuoBody™ teknologisamarbejde - Upfrontbetaling på USD 2 mio. til Genmab København, Danmark; 4. juni 2012 – Genmab A/S (OMX: GEN) har i dag...
June 04, 2012 01:55 ET | Source: Genmab A/S

Genmab Enters DuoBody Technology Collaboration

Company Announcement - Additional DuoBody™ technology collaboration - USD 2 million upfront payment to Genmab Copenhagen, Denmark; June 4, 2012 – Genmab A/S (OMX: GEN) announced today an...
May 30, 2012 02:46 ET | Source: Genmab A/S

Genmab udlicenserer HuMax-IL8

Pressemeddelelse - HuMax-IL8 udlicenseres til Cormorant Pharmaceuticals København, Danmark; 30. maj 2012 – Genmab A/S (OMX: GEN) har i dag meddelt, at selskabet har givet en eksklusiv og...
May 30, 2012 02:46 ET | Source: Genmab A/S

Genmab Outlicenses HuMax-IL8

Media Release - HuMax-IL8 licensed to Cormorant Pharmaceuticals Copenhagen, Denmark; May 30, 2012 – Genmab A/S (OMX: GEN) announced today it has granted an exclusive, worldwide license to its...